Analysis of Pharmaceuticals by Capillary Electrophoresis: CHROMATOGRAPHIA CE-Series, cartea 2
Autor Kevin D. Altriaen Limba Engleză Paperback – 9 feb 2012
Preț: 642.83 lei
Preț vechi: 756.27 lei
-15% Nou
Puncte Express: 964
Preț estimativ în valută:
123.02€ • 127.65$ • 102.82£
123.02€ • 127.65$ • 102.82£
Carte tipărită la comandă
Livrare economică 15-29 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9783322850133
ISBN-10: 3322850137
Pagini: 304
Ilustrații: XII, 285 p.
Dimensiuni: 170 x 240 x 16 mm
Greutate: 0.49 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: Vieweg+Teubner Verlag
Colecția Vieweg+Teubner Verlag
Seria CHROMATOGRAPHIA CE-Series
Locul publicării:Wiesbaden, Germany
ISBN-10: 3322850137
Pagini: 304
Ilustrații: XII, 285 p.
Dimensiuni: 170 x 240 x 16 mm
Greutate: 0.49 kg
Ediția:Softcover reprint of the original 1st ed. 1998
Editura: Vieweg+Teubner Verlag
Colecția Vieweg+Teubner Verlag
Seria CHROMATOGRAPHIA CE-Series
Locul publicării:Wiesbaden, Germany
Public țintă
Professional/practitionerCuprins
General introduction to CE principles, instrumentation and methodology - Determination of drug related impurities - Main component assay - Chiral separations - Drug counter-ion determinations - Identity confirmation testing - Clinical applications - Trace level determination of drugs and surfactants - Analysis of excipients and raw materials by CE - Analysis of biopharmaceuticals - Method performance optimization guidelines - Method validation - Critical comparison of CE with HPLC for pharmaceutical analysis - Miscellaneous: electrochromatography, vitamin analysis, radiopharmaceutical analysis, micro-preprative CE
Recenzii
"Das Buch bietet dem pharmazeutischen Chemiker eine gute Übersicht über die Möglichkeiten, die Kapillarelektrophorese für pharmazeutische Analysen einzusetzen, aber sich auch über deren Grundlagen und Entwicklungsmöglichkeiten zu informieren." (Fresenius Journal of Analytical Chemistry Nr. 1/99)
Notă biografică
Dr. Kevin D. Altria ist Wissenschaftler bei der Glaxo Company in Großbritannien.
The author, Dr. Kevin D. Altria, has been working in Glaxo Wellcome R & D for 10 years. During this time he has developed and implemented many routine pharmaceutical analysis CE methods.
The author, Dr. Kevin D. Altria, has been working in Glaxo Wellcome R & D for 10 years. During this time he has developed and implemented many routine pharmaceutical analysis CE methods.